TNSN04166A1 - Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a - Google Patents
Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin aInfo
- Publication number
- TNSN04166A1 TNSN04166A1 TNP2004000166A TNSN04166A TNSN04166A1 TN SN04166 A1 TNSN04166 A1 TN SN04166A1 TN P2004000166 A TNP2004000166 A TN P2004000166A TN SN04166 A TNSN04166 A TN SN04166A TN SN04166 A1 TNSN04166 A1 TN SN04166A1
- Authority
- TN
- Tunisia
- Prior art keywords
- formula
- substantially pure
- isostructural pseudopolymorphs
- deoxo
- aza
- Prior art date
Links
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title abstract 2
- 239000013078 crystal Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000010362 Protozoan Infections Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Finger-Pressure Massage (AREA)
- Instructional Devices (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Thermal Transfer Or Thermal Recording In General (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HR20020231A HRP20020231A2 (en) | 2002-03-18 | 2002-03-18 | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
| US39361202P | 2002-07-03 | 2002-07-03 | |
| US39470502P | 2002-07-08 | 2002-07-08 | |
| PCT/IB2003/000987 WO2003077830A2 (en) | 2002-03-18 | 2003-03-18 | 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN04166A1 true TNSN04166A1 (en) | 2007-03-12 |
Family
ID=28045976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2004000166A TNSN04166A1 (en) | 2002-03-18 | 2004-09-03 | Isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7569549B2 (OSRAM) |
| EP (2) | EP1485393B1 (OSRAM) |
| JP (1) | JP2005529082A (OSRAM) |
| KR (1) | KR20050002872A (OSRAM) |
| CN (1) | CN1642966A (OSRAM) |
| AT (1) | ATE440104T1 (OSRAM) |
| AU (1) | AU2003215779A1 (OSRAM) |
| BG (1) | BG108874A (OSRAM) |
| BR (1) | BR0308644A (OSRAM) |
| CA (1) | CA2479211A1 (OSRAM) |
| DE (1) | DE60328872D1 (OSRAM) |
| EA (1) | EA200401217A1 (OSRAM) |
| ES (1) | ES2331733T3 (OSRAM) |
| HR (2) | HRP20020231A2 (OSRAM) |
| IL (1) | IL163836A0 (OSRAM) |
| IS (1) | IS7449A (OSRAM) |
| MX (1) | MXPA04009009A (OSRAM) |
| NO (1) | NO20044341L (OSRAM) |
| NZ (1) | NZ535477A (OSRAM) |
| PL (1) | PL372468A1 (OSRAM) |
| RS (1) | RS82504A (OSRAM) |
| TN (1) | TNSN04166A1 (OSRAM) |
| WO (1) | WO2003077830A2 (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20020231A2 (en) | 2002-03-18 | 2003-12-31 | Pliva D D | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
| HRP20020614A2 (en) | 2002-07-22 | 2004-06-30 | PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. | Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
| EP1878432A1 (en) * | 2003-07-24 | 2008-01-16 | Pliva - Research and Development Ltd. | Single dose fast dissolving azithromycin |
| WO2005009447A1 (en) * | 2003-07-24 | 2005-02-03 | Pliva - Research And Development Ltd. | Single dose fast dissolving azithromycin |
| JP2007513139A (ja) | 2003-12-04 | 2007-05-24 | ファイザー・プロダクツ・インク | 安定性の改善した多粒子組成物 |
| US6984403B2 (en) * | 2003-12-04 | 2006-01-10 | Pfizer Inc. | Azithromycin dosage forms with reduced side effects |
| CA2547239A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Azithromycin multiparticulate dosage forms by liquid-based processes |
| CA2549225A1 (en) * | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride |
| WO2005053652A1 (en) | 2003-12-04 | 2005-06-16 | Pfizer Products Inc. | Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride |
| JP2007513145A (ja) * | 2003-12-04 | 2007-05-24 | ファイザー・プロダクツ・インク | 医薬用多微粒子の製造方法 |
| US7468428B2 (en) * | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
| US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI8110592A8 (en) | 1981-03-06 | 1996-06-30 | Pliva Pharm & Chem Works | Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof |
| RO107257B1 (ro) * | 1987-07-09 | 1993-10-30 | Pfizer | Procedeu de obtinere a unui dihidrat de azitromicina, cristalin |
| HRP20020231A2 (en) | 2002-03-18 | 2003-12-31 | Pliva D D | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
| ES2104386T3 (es) | 1993-05-19 | 1997-10-01 | Pfizer | Compuesto intermedio para la acitromicina. |
| HRP940251B1 (en) | 1994-04-15 | 1998-12-31 | Stjepan Mutak | Process for the preparation of azithromycin dihydrochloride |
| ES2122905B1 (es) * | 1996-07-11 | 1999-11-16 | Astur Pharma Sa | Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato). |
| PT102130A (pt) | 1998-03-13 | 1999-09-30 | Hovione Sociedade Quimica S A | Processo de preparacao de dihidrato de azitromicina |
| CN1205338A (zh) | 1998-05-08 | 1999-01-20 | 刘万忠 | 阿奇霉素水溶性盐的合成新方法及其在医药上的用途 |
| TW546302B (en) * | 1998-05-08 | 2003-08-11 | Biochemie Sa | Improvements in macrolide production |
| CA2245398C (en) | 1998-08-21 | 2002-01-29 | Apotex Inc. | Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof |
| JP2002531409A (ja) * | 1998-11-30 | 2002-09-24 | テバ ファーマシューティカル インダストリーズ リミティド | アジスロマイシンのエタノール付加物、その製造方法、及びその医薬製剤 |
| ATE469910T1 (de) * | 1999-06-29 | 2010-06-15 | Sandoz Ag | Azithromycinmonohydrat |
| ES2177373B1 (es) * | 1999-11-26 | 2003-11-01 | Astur Pharma Sa | Preparacion de azitromicina en su forma no cristalina |
| AU2928701A (en) | 2000-01-04 | 2001-07-16 | Teva Pharmaceutical Industries Ltd. | Preparation method of azithromycin dihydrate |
| ES2162764B1 (es) * | 2000-05-17 | 2003-04-01 | Ercros Ind Sa | Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion. |
| ATE320441T1 (de) * | 2000-07-25 | 2006-04-15 | Silanes Sa De Cv Lab | Einstufiges verfahren zur herstellung von 7,16- |
| DE60114028T2 (de) | 2000-08-23 | 2006-07-13 | Wockhardt Ltd. | Verfahren zur herstellung von wasserfreiem azithromycin |
| CA2429639C (en) | 2000-11-27 | 2009-07-14 | Biochemie S.A. | Stable azithromycin monohydrate |
| KR100491183B1 (ko) | 2001-03-21 | 2005-05-25 | 한미약품 주식회사 | 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물 |
| KR100431431B1 (ko) | 2001-04-25 | 2004-05-14 | 한미약품 주식회사 | 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물 |
| HRP20010301A2 (en) | 2001-04-27 | 2001-12-31 | Pliva D D | New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases |
| IL158591A0 (en) | 2001-05-22 | 2004-05-12 | Pfizer Prod Inc | Crystal forms of azithromycin |
| US6861413B2 (en) | 2001-05-22 | 2005-03-01 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
| EP1455757A2 (en) | 2001-12-21 | 2004-09-15 | Pfizer Products Inc. | Methods for wet granulating azithromycin |
| IL161996A0 (en) | 2001-12-21 | 2005-11-20 | Pfizer Prod Inc | Directly compressible formulations of azithromycin |
| BR0307331A (pt) | 2002-02-01 | 2004-12-07 | Pfizer Prod Inc | Formulações granuladas a seco de azitromicina |
| ITMI20021209A1 (it) | 2002-06-04 | 2003-12-04 | Chemi Spa | Processo di preparazione di azitromicina ad elevata purezza |
-
2002
- 2002-03-18 HR HR20020231A patent/HRP20020231A2/hr not_active Application Discontinuation
-
2003
- 2003-03-17 US US10/390,573 patent/US7569549B2/en not_active Expired - Lifetime
- 2003-03-18 MX MXPA04009009A patent/MXPA04009009A/es not_active Application Discontinuation
- 2003-03-18 ES ES03744475T patent/ES2331733T3/es not_active Expired - Lifetime
- 2003-03-18 RS YU82504A patent/RS82504A/sr unknown
- 2003-03-18 AU AU2003215779A patent/AU2003215779A1/en not_active Abandoned
- 2003-03-18 DE DE60328872T patent/DE60328872D1/de not_active Expired - Fee Related
- 2003-03-18 EP EP03744475A patent/EP1485393B1/en not_active Expired - Lifetime
- 2003-03-18 BR BR0308644-5A patent/BR0308644A/pt not_active Application Discontinuation
- 2003-03-18 EP EP05023731A patent/EP1627883A1/en not_active Withdrawn
- 2003-03-18 PL PL03372468A patent/PL372468A1/xx unknown
- 2003-03-18 CN CNA038063263A patent/CN1642966A/zh active Pending
- 2003-03-18 WO PCT/IB2003/000987 patent/WO2003077830A2/en not_active Ceased
- 2003-03-18 NZ NZ535477A patent/NZ535477A/en unknown
- 2003-03-18 JP JP2003575884A patent/JP2005529082A/ja not_active Abandoned
- 2003-03-18 CA CA002479211A patent/CA2479211A1/en not_active Abandoned
- 2003-03-18 EA EA200401217A patent/EA200401217A1/ru unknown
- 2003-03-18 AT AT03744475T patent/ATE440104T1/de not_active IP Right Cessation
- 2003-03-18 IL IL16383603A patent/IL163836A0/xx unknown
- 2003-03-18 HR HR20040858A patent/HRP20040858A2/xx not_active Application Discontinuation
- 2003-03-18 KR KR10-2004-7014757A patent/KR20050002872A/ko not_active Withdrawn
-
2004
- 2004-09-03 TN TNP2004000166A patent/TNSN04166A1/en unknown
- 2004-09-14 BG BG108874A patent/BG108874A/xx unknown
- 2004-09-16 IS IS7449A patent/IS7449A/is unknown
- 2004-10-13 NO NO20044341A patent/NO20044341L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003077830A2 (en) | 2003-09-25 |
| CA2479211A1 (en) | 2003-09-25 |
| EP1485393B1 (en) | 2009-08-19 |
| US7569549B2 (en) | 2009-08-04 |
| MXPA04009009A (es) | 2005-06-17 |
| JP2005529082A (ja) | 2005-09-29 |
| HRP20020231A2 (en) | 2003-12-31 |
| WO2003077830A3 (en) | 2004-05-13 |
| BR0308644A (pt) | 2005-01-25 |
| HRP20040858A2 (en) | 2005-06-30 |
| AU2003215779A1 (en) | 2003-09-29 |
| US20040014951A1 (en) | 2004-01-22 |
| NZ535477A (en) | 2006-11-30 |
| RS82504A (sr) | 2006-12-15 |
| IL163836A0 (en) | 2005-12-18 |
| DE60328872D1 (en) | 2009-10-01 |
| CN1642966A (zh) | 2005-07-20 |
| BG108874A (en) | 2005-12-30 |
| EP1485393A2 (en) | 2004-12-15 |
| KR20050002872A (ko) | 2005-01-10 |
| EP1627883A1 (en) | 2006-02-22 |
| ATE440104T1 (de) | 2009-09-15 |
| PL372468A1 (en) | 2005-07-25 |
| EA200401217A1 (ru) | 2005-02-24 |
| NO20044341L (no) | 2004-11-23 |
| IS7449A (is) | 2004-09-16 |
| ES2331733T3 (es) | 2010-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2444541T3 (es) | Oligómeros de alginato para usar para superar la multirresistencia a fármacos en bacterias | |
| Giamarellou et al. | In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa | |
| NZ514917A (en) | Ketolide antibacterials | |
| WO2003077830A3 (en) | 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives | |
| UA94901C2 (ru) | Антибактериальные производные пиперидина | |
| EA200000594A1 (ru) | Новые макролиды | |
| BRPI0514420A (pt) | peptìdeo, variante do mesmo, ou um sal farmaceuticamente aceitável do mesmo, composição, uso de um peptìdeo ou de uma variante de peptìdeo, substrato, e, métodos de tratamento ou prevenção de um infecção microbiana, e de tratamento de uma ferida em um indivìduo | |
| WO2010141133A3 (en) | Silk fibroin systems for antibiotic delivery | |
| TWI327573B (en) | 6-11 bicyclic ketolide derivatives | |
| NZ552047A (en) | Method of treatment of endobronchial infections | |
| NO20061657L (no) | Pyrolderivater med antibakteriell aktivitet | |
| WO2003004509A3 (en) | C12 modified erythromycin macrolides and ketolides having antibacterial activity | |
| AU2002222296A1 (en) | Macrolide antibiotics | |
| WO2008020227A3 (en) | Antibacterial pyrrolecarboxamides | |
| AP9801253A0 (en) | 9-Oxime erythromycin derivatives. | |
| AP2001002142A0 (en) | 13-membered azalides and their use as antibiotic agents. | |
| WO2009043987A9 (fr) | Compositions antibiotiques a base d'huiles essentielles - prophylaxie et traitement d'infections nosocomiales | |
| MX2009005982A (es) | Derivados de quinolina antibacterianos. | |
| HUP0004579A2 (hu) | Antibakteriális hatású, a 3'-N-pozícióban módosított szerkezetű 6-0-szubsztituált-eritromicin-ketolid-származékok és ezeket tartalmazó gyógyszerkészítmények | |
| EP1114826A3 (en) | Novel antibacterial and prokinetic macrolides | |
| CA2137395A1 (en) | 9a-N-(N'-Carbamoyl) and 9a-N-(N' - Thiocarbamoyl) Derivatives of 9-Deoxo-9a-AZA-9a-Homoerythromycin A | |
| WO2004009608A3 (en) | Novel amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a, process for preparing the same, and use thereof | |
| GEP20032970B (en) | Pharmaceutical Compositions of Tizoxanide and Nitazoxanide | |
| MY148124A (en) | Preparation of a crystalline antibiotic substance | |
| WO2003089446A3 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives |